Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus.
作者信息
Gnann J W, Nelson J A, Oldstone M B
出版信息
J Virol. 1987 Aug;61(8):2639-41. doi: 10.1128/JVI.61.8.2639-2641.1987.
Abstract
Sera from virtually all individuals infected with human immunodeficiency virus contain antibodies against the viral envelope glycoproteins. By using a series of synthetic peptide antigens, we identified an immunodominant domain at amino acid position 598-609 of gp41. The minimal essential epitope is a 7-amino-acid sequence (amino acids 603-609) containing two cysteine residues. Both cysteine residues are required for the antigenic conformation of the sequence, possibly due to creation of a cyclic structure via disulfide bond formation.
摘要
相似文献
1
Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus.
J Virol. 1987 Aug;61(8):2639-41. doi: 10.1128/JVI.61.8.2639-2641.1987.
2
Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus.
J Infect Dis. 1987 Aug;156(2):261-7. doi: 10.1093/infdis/156.2.261.
3
Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.
J Virol. 1993 Mar;67(3):1693-7. doi: 10.1128/JVI.67.3.1693-1697.1993.
4
Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.
Proc Natl Acad Sci U S A. 1988 Jul;85(14):5225-9. doi: 10.1073/pnas.85.14.5225.
5
Antigenic epitopes of the hepatitis A virus polyprotein.
Virology. 1999 Aug 1;260(2):260-72. doi: 10.1006/viro.1999.9813.
6
A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
J Virol. 2000 Jan;74(2):627-43. doi: 10.1128/jvi.74.2.627-643.2000.
7
Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins.
J Virol. 1987 Jun;61(6):2024-8. doi: 10.1128/JVI.61.6.2024-2028.1987.
8
Location of immunodominant antigenic determinants on fragments of the tick-borne encephalitis virus glycoprotein: evidence for two different mechanisms by which antibodies mediate neutralization and hemagglutination inhibition.
Virology. 1983 Oct 30;130(2):485-501. doi: 10.1016/0042-6822(83)90102-2.
9
Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins.
Clin Exp Immunol. 1987 Aug;69(2):231-9.
10
Monoclonal antibody identifies a highly conserved and immunodominant epitope of the human immunodeficiency virus transmembrane protein.
Hybridoma. 1988 Apr;7(2):117-28. doi: 10.1089/hyb.1988.7.117.
引用本文的文献
1
How to Detect Porcine Endogenous Retrovirus (PERV) Infections in Patients After Transplantation of Pig Organs.
Xenotransplantation. 2025 Jan-Feb;32(1):e70028. doi: 10.1111/xen.70028.
2
Epitope length variants balance protective immune responses and viral escape in HIV-1 infection.
Cell Rep. 2022 Mar 1;38(9):110449. doi: 10.1016/j.celrep.2022.110449.
3
Antibody response against selected epitopes in the HIV-1 envelope gp41 ectodomain contributes to reduce viral burden in HIV-1 infected patients.
Sci Rep. 2021 Apr 26;11(1):8993. doi: 10.1038/s41598-021-88274-9.
4
Identification of HIV gp41-specific antibodies that mediate killing of infected cells.
PLoS Pathog. 2019 Feb 19;15(2):e1007572. doi: 10.1371/journal.ppat.1007572. eCollection 2019 Feb.
5
Env-Specific Antibodies in Chronic Infection versus in Vaccination.
Front Immunol. 2017 Sep 4;8:1057. doi: 10.3389/fimmu.2017.01057. eCollection 2017.
6
Molecular and Physicochemical Factors Governing Solubility of the HIV gp41 Ectodomain.
Biophys J. 2016 Aug 23;111(4):700-709. doi: 10.1016/j.bpj.2016.07.022.
7
Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.
PLoS One. 2016 May 9;11(5):e0152038. doi: 10.1371/journal.pone.0152038. eCollection 2016.
8
Comparison of the specificities of IgG, IgG-subclass, IgA and IgM reactivities in African and European HIV-infected individuals with an HIV-1 clade C proteome-based array.
PLoS One. 2015 Feb 6;10(2):e0117204. doi: 10.1371/journal.pone.0117204. eCollection 2015.
9
Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial.
PLoS One. 2013 Sep 26;8(9):e75665. doi: 10.1371/journal.pone.0075665. eCollection 2013.
10
Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.
PLoS One. 2013 Sep 6;8(9):e72205. doi: 10.1371/journal.pone.0072205. eCollection 2013.
本文引用的文献
1
Antibodies of predetermined specificity in biology and medicine.
Adv Immunol. 1984;36:1-44. doi: 10.1016/s0065-2776(08)60898-6.
2
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.
Science. 1984 May 4;224(4648):500-3. doi: 10.1126/science.6200936.
3
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).
Science. 1983 May 20;220(4599):868-71. doi: 10.1126/science.6189183.
4
Antibodies that react with predetermined sites on proteins.
Science. 1983 Feb 11;219(4585):660-6. doi: 10.1126/science.6186024.
5
Prediction of protein antigenic determinants from amino acid sequences.
Proc Natl Acad Sci U S A. 1981 Jun;78(6):3824-8. doi: 10.1073/pnas.78.6.3824.
6
Human pituitary growth hormone. XVI. Reduction with dithiothreitol in the absence of urea.
Biochim Biophys Acta. 1968 Feb 19;154(2):420-2. doi: 10.1016/0005-2795(68)90116-5.
7
Solid-phase peptide synthesis.
Adv Enzymol Relat Areas Mol Biol. 1969;32:221-96. doi: 10.1002/9780470122778.ch6.
8
Prediction of HIV vaccine.
Nature. 1987;325(6103):395. doi: 10.1038/325395a0.
9
AIDS in Africa: an epidemiologic paradigm.
Science. 1986 Nov 21;234(4779):955-63. doi: 10.1126/science.3022379.
10
Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein.
Science. 1986 Mar 28;231(4745):1556-9. doi: 10.1126/science.3006246.
Zotero 插件